• Tropisetron Hydrochloride: Beyond 5-HT3 Antagonism in Resear

  2026-08-06

  Explore Tropisetron Hydrochloride as a leading 5-HT3 receptor antagonist for advanced serotonin receptor signaling research. This article reveals new mechanistic insights from transporter inhibition studies, bridging molecular pharmacology with practical assay design.

• Synergistic Colistin–Gamithromycin Action Against P. multoci

  2026-08-06

  This study demonstrates that combining colistin with gamithromycin significantly enhances antimicrobial activity against Pasteurella multocida in a neutropenic murine lung infection model. The findings reveal potent synergy, particularly for high-colistin MIC isolates, and offer insights into optimizing therapeutic regimens to combat resistance in veterinary pathogens.

• Murine RNase Inhibitor (K1046): Reliable RNA Protection in A

  2026-08-05

  This article details real laboratory challenges in RNA-based assays, demonstrating how Murine RNase Inhibitor (SKU K1046) delivers robust RNA degradation prevention and workflow reproducibility. Scenario-based Q&A provides actionable insight for biomedical researchers, with cited data and practical protocols to ensure assay sensitivity and reliability.

• SB 431542: Selective ALK5 Inhibitor for TGF-β Pathway Studie

  2026-08-05

  SB 431542 is a potent, selective ALK5 inhibitor widely used to dissect TGF-β signaling in cellular and animal models. It blocks Smad2 phosphorylation, impacts cell proliferation, and demonstrates immunomodulatory effects, with robust selectivity and solubility features for research applications.

• Difloxacin HCl: Applied Workflows in Antimicrobial and MDR R

  2026-08-04

  Difloxacin HCl stands apart as a quinolone antimicrobial antibiotic, uniquely enabling both robust antimicrobial susceptibility testing and innovative multidrug resistance (MDR) reversal assays. This article bridges advanced research use-cases, stepwise protocol enhancements, and troubleshooting strategies—all leveraging APExBIO’s high-purity Difloxacin HCl.

• Amyloid Beta-peptide (25-35): Advanced Neuroinflammation Ins

  2026-08-04

  Explore Amyloid Beta-peptide (25-35) (human) as a versatile model for dissecting neuroinflammatory processes in Alzheimer’s disease research. This article offers a unique focus on its utility for microglial phenotype modulation and translational assay strategies.

• PEDV Exploits IMPDH-Dependent Nucleotide Biosynthesis for Re

  2026-08-03

  This study reveals that porcine epidemic diarrhea virus (PEDV) reprograms host nucleotide metabolism, specifically hijacking IMPDH-dependent guanine biosynthesis, to facilitate its replication. Both genetic and pharmacological inhibition of IMPDH—using Merimepodib (VX-497)—markedly suppresses PEDV, highlighting IMPDH as a promising host-directed antiviral target.

• Homoharringtonine: Cytotoxic Alkaloid Benchmarks in Cancer &

  2026-08-03

  Homoharringtonine is a cytotoxic alkaloid with defined activity against leukemic cells and SARS-CoV-2. Its mechanism—80S ribosome binding and protein synthesis inhibition—enables precise cell cycle arrest. This article details molecular rationale, evidence, and protocol integration for research applications.

• Panobinostat (LBH589) and Apoptosis: New Insights for Cancer

  2026-08-02

  Explore how Panobinostat (LBH589) drives apoptosis in cancer cells through novel HDAC inhibition and links to recent discoveries on RNA Pol II-mediated cell death. This article offers a deeper, evidence-based perspective for advanced epigenetic and apoptosis research.

• NP-40 Lysis Buffer: Robust Non-Denaturing Protein Extraction

  2026-08-01

  APExBIO's NP-40 Lysis Buffer stands out as a non-denaturing solution enabling high-yield, native protein extraction from diverse biological sources. Its gentle yet effective lysis supports complex neuroimmunology workflows, including co-immunoprecipitation and phosphoprotein analysis, crucial for dissecting cell signaling in disease models.

• Cl-Amidine trifluoroacetate salt: Advanced PAD4 Inhibition i

  2026-07-31

  Explore the unique translational power of Cl-Amidine trifluoroacetate salt as a PAD4 inhibitor for dissecting immune and epigenetic mechanisms in cancer and sepsis. This article delivers a deep, evidence-based analysis of its applications, mechanistic selectivity, and best-practice protocols.

• Deep Learning of USC Mitochondrial Morphology for AD Detecti

  2026-07-31

  This study pioneers a deep learning framework to analyze mitochondrial morphology in urine-derived stem cells as a non-invasive biomarker for Alzheimer’s disease. The approach demonstrates robust discrimination of mitochondrial alterations linked to cognitive impairment, offering new potential for early AD detection and minimally invasive monitoring.

• BMS 309403 and the CaN/FoxO1/FABP4 Axis: Breakthroughs in Ca

  2026-07-30

  Explore how BMS 309403, a potent FABP4 inhibitor, uniquely enables advanced investigation of the CaN/FoxO1/FABP4 pathway in atherosclerosis and metabolic disease. This article delivers deep mechanistic insights and practical assay guidance beyond standard workflows.

• WZ4003: A Selective NUAK1/2 Inhibitor for Cell Migration and

  2026-07-30

  WZ4003 enables precise inhibition of NUAK1/2 kinases, empowering researchers to dissect cell migration, proliferation, and tau phosphorylation with high specificity. Its robust performance in both cancer biology and neurodegeneration models sets it apart as a versatile chemical probe for translational studies.

• ECL Chemiluminescent Substrate Detection Kit: Omics-Ready Pr

  2026-07-29

  Explore the ECL Chemiluminescent Substrate Detection Kit for advanced Western blot chemiluminescence detection, integrating omics analysis and mechanistic insight. This article uniquely bridges molecular assay optimization with cutting-edge systems biology findings.

455 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page